4030
Two phase II trials of 24 - hour paclitaxel infusions in chemotherapy - naive patients with stage IIIB or IV non - small cell lung cancer ( NSCLC ) reported response rates of 21 % and 24 % .
 Chemical: paclitaxel; Disease: non - small cell lung cancer; Disease: NSCLC
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: paclitaxel; Disease: non - small cell lung cancer; Disease: NSCLC